Real-world evidence and regulatory drug approval

Nat Rev Clin Oncol. 2020 May;17(5):271-272. doi: 10.1038/s41571-020-0345-7.

Michael J Raphael^{1

2

3}, Bishal Gyawali^{1

2

3

4}, Christopher M Booth^{5

6

7}

¹ Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
² Department of Oncology, Queen's University, Kingston, Canada.
³ Department of Public Health Sciences, Queen's University, Kingston, Canada.
⁴ Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
⁵ Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada. booth@queensu.ca.
⁶ Department of Oncology, Queen's University, Kingston, Canada. booth@queensu.ca.
⁷ Department of Public Health Sciences, Queen's University, Kingston, Canada. booth@queensu.ca.

No abstract available

Publication types